This site is intended for healthcare professionals
News

Molecular Partners announces collaboration with Novartis to develop two DARPin therapies designed for potential use against COVID-19.

Read time: 1 mins
Last updated:29th Oct 2020
Published:29th Oct 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com